Date | Time | Source | Headline | Symbol | Company |
09/17/2024 | 5:32PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:ILMN | Illumina Inc |
09/09/2024 | 5:18PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:ILMN | Illumina Inc |
09/09/2024 | 4:02PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:ILMN | Illumina Inc |
09/05/2024 | 5:27PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:ILMN | Illumina Inc |
09/05/2024 | 5:26PM | Edgar (US Regulatory) | Form 424B2 - Prospectus [Rule 424(b)(2)] | NASDAQ:ILMN | Illumina Inc |
09/04/2024 | 10:02AM | Edgar (US Regulatory) | Form 424B2 - Prospectus [Rule 424(b)(2)] | NASDAQ:ILMN | Illumina Inc |
09/04/2024 | 9:02AM | Edgar (US Regulatory) | Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers | NASDAQ:ILMN | Illumina Inc |
09/04/2024 | 5:50AM | IH Market News | Nvidia Subpoenaed by DOJ, Athira Pharma Shares Plunge 71% After Study Fails, Zscaler Falls 15% Post-Earnings | NASDAQ:ILMN | Illumina Inc |
08/29/2024 | 4:16PM | PR Newswire (US) | Results of GRAIL's GalleriĀ® Multi-Cancer Early Detection Blood Test in Prostate Cancer Published in JCO Precision Oncology | NASDAQ:ILMN | Illumina Inc |
08/27/2024 | 9:15AM | PR Newswire (US) | FDA approves Illumina cancer biomarker test with two companion diagnostics to rapidly match patients to targeted therapies | NASDAQ:ILMN | Illumina Inc |
08/19/2024 | 4:21PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:ILMN | Illumina Inc |
08/15/2024 | 4:31PM | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NASDAQ:ILMN | Illumina Inc |
08/14/2024 | 4:49PM | Edgar (US Regulatory) | Form SC 13G - Statement of Beneficial Ownership by Certain Investors | NASDAQ:ILMN | Illumina Inc |
08/13/2024 | 11:00AM | PR Newswire (US) | Illumina announces strategy to accelerate value creation | NASDAQ:ILMN | Illumina Inc |
08/07/2024 | 5:28PM | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:ILMN | Illumina Inc |
08/07/2024 | 5:42AM | IH Market News | Novo Nordisk Adjusts Outlook, Airbnb Drops 16% on Declining U.S. Demand, Lumen Technologies Surges 48% in Premarket | NASDAQ:ILMN | Illumina Inc |
08/06/2024 | 4:20PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:ILMN | Illumina Inc |
08/06/2024 | 4:05PM | PR Newswire (US) | Illumina Reports Financial Results for Second Quarter of Fiscal Year 2024 | NASDAQ:ILMN | Illumina Inc |
08/06/2024 | 5:49AM | IH Market News | US Index Futures Rise After Market Sell-off, Oil Prices Trim Losses | NASDAQ:ILMN | Illumina Inc |
08/05/2024 | 9:15AM | PR Newswire (US) | Illumina launches new oncology menu for NovaSeq X Series customers | NASDAQ:ILMN | Illumina Inc |
07/31/2024 | 6:01AM | IH Market News | US Index Futures Up Ahead of Fed Decision; Oil Prices Surge Amid Middle East Tensions | NASDAQ:ILMN | Illumina Inc |
07/18/2024 | 4:05PM | PR Newswire (US) | Illumina to Present Upcoming Strategy Update | NASDAQ:ILMN | Illumina Inc |
07/11/2024 | 4:05PM | PR Newswire (US) | Illumina to Announce Second Quarter 2024 Financial Results on Tuesday, August 6, 2024 | NASDAQ:ILMN | Illumina Inc |
07/11/2024 | 6:17AM | IH Market News | Costco Hikes Membership Fees; ON Semiconductor Stock Drops 3%; WD-40 Soars 13% on Strong Q3 Earnings | NASDAQ:ILMN | Illumina Inc |
07/09/2024 | 7:28PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:ILMN | Illumina Inc |
07/09/2024 | 4:05PM | PR Newswire (US) | Illumina acquires Fluent BioSciences to accelerate single-cell analysis and discovery to a broader customer base | NASDAQ:ILMN | Illumina Inc |
06/28/2024 | 6:50AM | IH Market News | Nike Stock Drops 14% in Pre-Market; Nokia Acquires Infinera for $2.3 Billion, and More News | NASDAQ:ILMN | Illumina Inc |
06/25/2024 | 6:36AM | IH Market News | SolarEdge Stock Falls 13%, Wegovy Approved in China, Grail Nasdaq Debut, Apple Rejects Meta Chatbot | NASDAQ:ILMN | Illumina Inc |
06/24/2024 | 4:05PM | PR Newswire (US) | Illumina completes the divestiture of GRAIL | NASDAQ:ILMN | Illumina Inc |
06/17/2024 | 8:29AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:ILMN | Illumina Inc |